Incorporation of Treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
2017; Springer Science+Business Media; Volume: 24; Issue: 12 Linguagem: Inglês
10.1245/s10434-017-6010-4
ISSN1534-4681
AutoresJohn R. Bergquist, Brittany L. Murphy, Curtis B. Storlie, Elizabeth B. Habermann, Judy C. Boughey,
Tópico(s)HER2/EGFR in Cancer Research
Referência(s)